drug

SER-155

Phase 1updated 3mo ago

by $MCRB Seres Therapeutics, Inc.

Phase 1

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying SER-155

phase1A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCTcompletedn=60

News(2)

Kolon TissueGene cuts 37 US staffers after Phase 3 fail
Follow along as BioSpace tracks job cuts and restructuring initiatives.
biospace · 1d ago
Fierce Biotech Layoff Tracker 2026: Kolon cuts workforce after ph. 3 fail; Sanofi sheds 229 staffers
As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.
fiercebiotech · 8mo ago

Data sources

ClinicalTrials.gov

last refreshed 9m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

SER-155

Phase 1updated 3mo ago

by $MCRB Seres Therapeutics, Inc.

Phase 1

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying SER-155

phase1A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCTcompletedn=60

News(2)

Kolon TissueGene cuts 37 US staffers after Phase 3 fail
Follow along as BioSpace tracks job cuts and restructuring initiatives.
biospace · 1d ago
Fierce Biotech Layoff Tracker 2026: Kolon cuts workforce after ph. 3 fail; Sanofi sheds 229 staffers
As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.
fiercebiotech · 8mo ago

Data sources

ClinicalTrials.gov

last refreshed 9m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

SER-155

all catalysts(0)

Trials studying SER-155

News(2)

Report a data issue

comments(0)

SER-155

all catalysts(0)

Trials studying SER-155

News(2)

Report a data issue

comments(0)